If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Software Group Regulatory News (APTD)

Share Price Information for Aptitude Software Group (APTD)

Share Price is delayed by 15 minutes
Get Live Data
203.00    -10.00 (-4.69%)
Bid:
202.00
Ask:
204.00
Spread: 2.00 (0.99%)
Market Cap: £108.65m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Software Group Share Chart

Interim Management Statement and Special Dividend

1 Nov 2011 07:00

RNS Number : 2017R
Microgen PLC
01 November 2011
 



microgen

www.microgen.com

 

1 November 2011

 

INTERIM MANAGEMENT STATEMENT AND SPECIAL DIVIDEND

 

Microgen plc ('Microgen' or 'the Group') provides its Interim Management Statement covering the period from 1 July 2011 to the date of this announcement. Microgen released its interim results for the six months ending 30 June 2011 on 21 July 2011.

 

There have been no significant changes since 1 July 2011 in the trading or financial position of Microgen and its balance sheet remains strong. In September, Microgen repaid the £1.6 million loan associated with its Fleet freehold property, after which the Group had cash at 30 September 2011 of £26.0 million (Net Funds at 30 June 2011 : £25.2 million).

 

Since 1 July 2011 the Microgen Aptitude Solutions Division ("MASD") has further expanded its customer base and the Financial Systems Division ("FSD") continues to perform satisfactorily in a flat market environment. Due in part to the consultancy demand on a number of projects in 2011, the Group's performance is now anticipated to be moderately ahead of the Board's expectations for the year, although the Board remains cautious due to the current macro-economic environment.

 

As a result of the strong financial position of Microgen, the Board has decided to pay a special dividend of 5.0 pence per share. The special dividend will be paid on 9 December 2011 to shareholders on the register as at 11 November 2011.

 

Three years ago, in October 2008, the Board introduced the Value Enhancement and Realisation Bonus Scheme ("VERBS"), at which time the market capitalisation of Microgen was £37.0 million. Including the forthcoming special dividend the Board has, since the introduction of VERBS, returned £28.2 million to shareholders through a progressive dividend policy, special dividends and tender offers. This is equivalent to over 75% of the Group's market capitalisation at the time of the introduction of VERBS. Furthermore, Microgen's market capitalisation, at 31 October 2011, has increased to £122.9 million.

 

 

 

Contacts

Martyn Ratcliffe, Chairman 020-7496-8100

David Sherriff, Chief Executive Officer

Philip Wood, Group Finance Director

 

James Melville-Ross, FTI Consulting 020-7831-3113

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUAABRAOAROAA
Date   Source Headline
29th Apr 20257:00 amRNSNotice of 2025 Annual General Meeting
29th Apr 20257:00 amRNSTransaction in Own Shares
28th Apr 20257:00 amRNSTransaction in Own Shares
22nd Apr 20254:16 pmRNSExercise of awards under the Aptitude 2020 DBP
7th Apr 20257:00 amRNSTransaction in Own Shares
4th Apr 20257:00 amRNSTransaction in Own Shares
3rd Apr 20257:00 amRNSAptitude Fynapse New Contract Win
3rd Apr 20257:00 amRNSTransaction in Own Shares
1st Apr 202511:49 amRNSTotal Voting Rights
31st Mar 202510:29 amRNSNotification of Major Holdings
31st Mar 202510:11 amRNSBLOCK LISTING SIX MONTHLY RETURN
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20255:01 pmRNSNotification of Major Holdings
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20255:10 pmRNSDirectorate Change
26th Mar 20257:00 amRNSAudited Results for Year Ended 31 December 2024
20th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20258:46 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:01 amRNSBoard Transition
5th Feb 20257:00 amRNSFull Year Trading Update and Notice of Results
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 202510:43 amRNSTotal Voting Rights
31st Jan 20255:39 pmRNSNotification of Major Holdings
30th Jan 20254:58 pmRNSNotification of Major Holdings
30th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares
23rd Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 202510:41 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.